AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Climb Bio, Inc. Director's Dealing 2021

Aug 10, 2021

33982_dirs_2021-08-09_969ed1bb-b3ae-4504-96df-2332cb056fc4.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Eliem Therapeutics, Inc. (ELYM)
CIK: 0001768446
Period of Report: 2021-08-09

Reporting Person: Ratcliffe Liam (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned.	0	Direct